Show simple item record

dc.contributor.authorPowell, Katieen_US
dc.contributor.authorLaakso, Liisaen_US
dc.contributor.authorMcDonnell, Annen_US
dc.contributor.authorRalph, Stephenen_US
dc.date.accessioned2017-05-03T14:11:53Z
dc.date.available2017-05-03T14:11:53Z
dc.date.issued2008en_US
dc.date.modified2011-03-10T08:10:55Z
dc.identifier.urihttp://hdl.handle.net/10072/37109
dc.description.abstractThe in vitro effects of a single exposure of LASER irradiation on human breast carcinoma and immortalised human mammary epithelial cell lines. Katie Powell(1&2), Dr Liisa Laakso(2), Dr Ann McDonnell(1), Dr Pauline Low(2), Dr Steve Ralph(2); Griffith University, Brisbane(1) and Gold Coast(2), Australia. PURPOSE: This research examined the cell proliferative response of two breast cancer cell lines and two immortalised human mammary epithelial cell lines in vitro to a range of doses of low level laser therapy (LLLT) at wavelengths of 780 nm, 830 nm and 904 nm. RELEVANCE: LLLT is used in the clinical treatment of post-mastectomy lymphoedema, although specific information on safety is scant and circumstantial. This presentation describes the first steps in gaining disease-specific knowledge upon which to develop guidelines for the safe clinical use of lasers in the management of post-mastectomy lymphoedema. METHODS: Human breast adenocarcinoma (MCF-7), human breast ductal carcinoma (MDA-MB-435S) and immortalised human mammary epithelial (SVCT and Bre80hTERT) cell lines were irradiated with a single exposure of laser at 0.5, 1, 2, 3, 4, 10 and 12 J/cm2 (?=780 nm) and 0.5, 1, 2, 3, 4, 10 and 15 J/cm2 (?=830 nm and 904 nm). Cell proliferation was assessed 24 hours after laser using XTT colorimetric assays. RESULTS: SVCT cell proliferation significantly increased after exposure to doses of 0.5, 1, 2, 3, 4, and 12 J/cm2 of laser at 780 nm and doses of 0.5, 1, 2, 4 and 10 J/cm2 of laser at 904 nm. The MDA-MB-435S and Bre80hTERT cell lines showed negligible effects with one exposure from all three wavelengths of laser and no dose response relationships were noted. The MCF-7 cells demonstrated an increasing dose response relationship with one exposure of 780 nm laser; and there were no dose response effects evident after exposure to 830 nm and 904 nm laser irradiation. CONCLUSIONS: Even though certain doses of laser increased MCF-7 cell proliferation, the amount of laser light penetrating through the skin clinically is considerably attenuated. Further in vivo research of LLLT is required before a definitive conclusion can be made regarding the safety of LLLT for post-mastectomy lymphoedema.en_US
dc.description.publicationstatusYesen_AU
dc.languageEnglishen_US
dc.language.isoen_AU
dc.publisherNo data provideden_US
dc.relation.ispartofstudentpublicationYen_AU
dc.relation.ispartofconferencenameNZ Laser 2008en_US
dc.relation.ispartofconferencetitleLaser Therapy Vol 17 No 1, March 2008en_US
dc.relation.ispartofdatefrom2008-04-25en_US
dc.relation.ispartofdateto2008-04-27en_US
dc.relation.ispartoflocationQueenstownen_US
dc.rights.retentionYen_AU
dc.subject.fieldofresearchcode320307en_US
dc.titleThe in vitro effects of a single exposure of LASER irradiation on human breast carcinoma and immortalised human mammary epithelial cell linesen_US
dc.typeConference outputen_US
dc.type.descriptionE3 - Conference Publications (Extract Paper)en_US
dc.type.codeE - Conference Publicationsen_US
gro.facultyGriffith Health, School of Medical Scienceen_US
gro.date.issued2008
gro.hasfulltextNo Full Text


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

  • Conference outputs
    Contains papers delivered by Griffith authors at national and international conferences.

Show simple item record